We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT04841434
Brief Title: A Phase I/II Study to Investigate the Use of VORAXAZE™ as Intended Intervention in Patients With CNSL (VALIDATE)

First Submitted : April 8, 2021
First Submitted that Met QC Criteria : April 8, 2021
First Posted : April 12, 2021

Last Update Submitted that Met QC Criteria : July 18, 2022
Last Update Posted : July 19, 2022